| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3218208
Max Phase: Preclinical
Molecular Formula: C9H10N3O6P
Molecular Weight: 287.17
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CNC(=O)c1oc(N)nc1-c1ccc(P(=O)(O)O)o1
Standard InChI: InChI=1S/C9H10N3O6P/c1-11-8(13)7-6(12-9(10)18-7)4-2-3-5(17-4)19(14,15)16/h2-3H,1H3,(H2,10,12)(H,11,13)(H2,14,15,16)
Standard InChI Key: JBTIPCKQKYSTJH-UHFFFAOYSA-N
Associated Targets(Human)
FBP1 Tchem Fructose-1,6-bisphosphatase (1199 Activities)
Associated Targets(non-human)
Rattus norvegicus (775804 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Fbp1 Fructose-1,6-bisphosphatase (106 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 287.17 | Molecular Weight (Monoisotopic): 287.0307 | AlogP: -0.32 | #Rotatable Bonds: 3 |
| Polar Surface Area: 151.82 | Molecular Species: ACID | HBA: 6 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 1.23 | CX Basic pKa: | CX LogP: -2.08 | CX LogD: -5.17 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.56 | Np Likeness Score: -0.34 |
References
| 1. Dang Q, Kasibthatla SR, Jiang T, Taplin F, Gibson T, Potter SC, van Poelje PD, Erion MD. (2011) Oxazole phosphonic acids as fructose 1,6-bisphosphatase inhibitors with potent glucose-lowering activity, 2 (4): [10.1039/C0MD00269K] |
Source
Source(1):